A detailed history of Sih Partners, Lllp transactions in Astrazeneca PLC stock. As of the latest transaction made, Sih Partners, Lllp holds 12,195 shares of AZN stock, worth $1.09 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
12,195
Previous 12,261 0.54%
Holding current value
$1.09 Million
Previous $857 Million 9.2%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$68.72 - $82.11 $4,535 - $5,419
-66 Reduced 0.54%
12,195 $936 Million
Q2 2025

Aug 14, 2025

SELL
$64.87 - $75.0 $2.36 Million - $2.73 Million
-36,409 Reduced 74.81%
12,261 $857 Million
Q1 2025

May 15, 2025

BUY
$65.37 - $77.96 $2.4 Million - $2.86 Million
36,721 Added 307.31%
48,670 $3.58 Billion
Q4 2024

Feb 14, 2025

BUY
$63.2 - $79.58 $755,176 - $950,901
11,949 New
11,949 $783 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $277B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Sih Partners, Lllp Portfolio

Follow Sih Partners, Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sih Partners, Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Sih Partners, Lllp with notifications on news.